Source notes

Does losing weight quickly mean regaining more of it later? In a hospital-based study, 200 adults with obesity entered either a 12-week rapid-loss program or a 36-week gradual-loss program. Both aimed for a 15% reduction in starting weight. Participants who lost at least 12.5% then entered a 144-week maintenance phase. Among those who completed that phase, each group regained about 71% of the weight previously lost. An analysis accounting for participants who did not complete follow-up also found similar regain between groups.

More participants in the rapid group reached the threshold for maintenance: about 81%, compared with 50% in the gradual group. This matters because the later comparison involved people who had already achieved substantial loss. The results challenge the claim that faster loss necessarily leads to faster regain under these conditions. They do not establish that every rapid diet is equally effective, appropriate or safe.

How Does This Show Up in Real Life?

A promise about keeping weight off needs evidence extending beyond the initial diet. This study followed a maintenance period lasting nearly three years, making that distinction central to its meaning. It suggests that the pace of initial loss alone did not explain later regain in these selected participants. The substantial regain in both groups also shows why reaching an early target and maintaining it are separate challenges. The tested programs were organized dietary interventions for adults with a body mass index between 30 and 45, not an evaluation of unsupervised crash dieting. The accessible summary does not provide enough detail to reproduce the diets or their support arrangements, so it cannot supply a practical program for an individual.

Only the abstract was accessible, limiting assessment of adherence, missing-data methods and treatment delivery. Participants and staff were not masked to assignment. Selection into maintenance and dropout affect interpretation. One rapid-group participant developed gallbladder inflammation requiring surgery during initial treatment. This reported event warrants attention but does not by itself establish a comparative safety rate or prove its cause.

Why We Cite It

Alpekin can use this source to examine the evidence behind familiar assumptions about behavior change. It illustrates why the people entering a follow-up phase must be identified clearly, and why a later outcome should be interpreted alongside the selection process that determined who was followed.

The trial offers a meaningful challenge to a simple rule, with important limits on its reach. It supports judging weight-management claims by their actual follow-up and study population, while leaving individual treatment choice and broader safety questions to a fuller assessment.